Stay updated on Tepotinib & Gefitinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib & Gefitinib in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.6, replacing the previous v3.6.5. This is a minor, behind-the-scenes update that does not alter the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-01T21:46:22.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A new line '2016 ( U.S. NIH Grant/Contract )' was added to the study overview alongside other identifiers, representing an additional funding reference for the INSIGHT trial.
    Difference
    0.0%
    Check dated 2026-08-25T22:15:33.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The revision label on the page was updated to v3.6.5, replacing the previous v3.6.4, indicating a new build or update to the underlying page.
    Difference
    0.0%
    Check dated 2026-08-11T21:38:40.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.6.4 replaces the previous v3.6.3, indicating a minor update to the page's metadata. The update does not alter study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-28T14:46:54.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.0 to v3.6.3, signaling a newer site build; no visible content changes to the study details are expected.
    Difference
    0.0%
    Check dated 2026-06-30T01:11:04.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page now includes a recruitment status update 'No longer looking for participants' and adds new help/navigation links (How to Read a Study Record, Common Questions, How to Join a Study). A Revision: v3.6.0 notice was added, and the Intervention/Treatment heading formatting was adjusted while the older Revision: v3.5.5 note was removed.
    Difference
    0.3%
    Check dated 2026-06-15T18:47:21.000Z thumbnail image

Stay in the know with updates to Tepotinib & Gefitinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.